Access Bio has ranked among the top searched stocks on 8 days within the past month.


As of 10:30 AM on the 13th, Access Bio is trading at 40,000 KRW, up 13.8% from the previous day. This marks a 75.44% increase compared to September 25. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past 5 days, individual investors have net purchased 605,470 shares, while foreigners and institutions have net sold 577,892 shares and net purchased 6,107 shares, respectively.


On October 12, Access Bio became a market topic with the headline "Rise following US FDA approval of COVID-19 diagnostic kit."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing